drugset / Trial / NCT01586208
Refractory Status Epilepticus Treatment Study
Phase 3
Completed
5 enrolled
Hospital Universitari de Bellvitge
Germans Trias i Pujol Hospital · collabHospital Clinic of Barcelona · collabHospital Vall d'Hebron · collabInstitut d'Investigació Biomèdica de Girona Dr. Josep Trueta · collab
RandomizedSingle-groupSingle-blindTreatment
Summary
Identify the most effective dose of valproic acid when used in combination with phenytoin for treatment of patients with refractory status epilepticus, which allow a better clinical course and prognosis of the disease.
Timeline
- Start
- 2010-01
- Primary completion
- 2012-05
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Valproic Acid | Small molecule | 20 mg/kg | — |
| Comparator | Valproic Acid | Small molecule | 40 mg/kg | — |